1. Home
  2. SPRY vs INN Comparison

SPRY vs INN Comparison

Compare SPRY & INN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$6.02

Market Cap

788.5M

Sector

Health Care

ML Signal

HOLD

INN

Summit Hotel Properties Inc.

HOLD

Current Price

$7.04

Market Cap

708.7M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRY
INN
Founded
2015
N/A
Country
United States
United States
Employees
N/A
78
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
788.5M
708.7M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
SPRY
INN
Price
$6.02
$7.04
Analyst Decision
Strong Buy
Sell
Analyst Count
1
2
Target Price
$40.00
$4.50
AVG Volume (30 Days)
2.3M
1.0M
Earning Date
05-11-2026
04-30-2026
Dividend Yield
N/A
6.41%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$84,278,000.00
N/A
Revenue This Year
$87.40
$2.00
Revenue Next Year
$81.64
$1.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.77
$3.98
52 Week High
$18.63
$7.15

Technical Indicators

Market Signals
Indicator
SPRY
INN
Relative Strength Index (RSI) 28.16 64.39
Support Level N/A $4.76
Resistance Level $8.61 $7.15
Average True Range (ATR) 0.44 0.18
MACD -0.18 0.01
Stochastic Oscillator 13.90 88.27

Price Performance

Historical Comparison
SPRY
INN

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

About INN Summit Hotel Properties Inc.

Summit Hotel Properties Inc is a U.S.-based hotel investment company focusing on select-service hotels in the upscale and upper-midscale properties in the U.S. Substantially all of Summit's assets are held and operated by its Operating Partnership, Summit Hotel OP, LP, in which the company holds general and limited partnership interests. The firm has one segment in activities related to investing in real estate. Summit's revenue streams include Room and Other hotel operations revenue. Room comprises the majority of total revenues. The company's hotels are located in various markets, such as corporate offices, retail centers, airports, state capitols, convention centers, and leisure attractions. Summit's hotels operate under brands, including Marriott, Hilton, Hyatt, and Holiday Inn.

Share on Social Networks: